Aqueous Sugar Film Coating System

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-02-02-2018
Volume 42
Issue 2

Colorcon's Opadry SGR, Rapid Sugar Film Coating System, is an aqueous, high-gloss sugar film coating system for pharmaceutical products.

Colorcon’s Opadry SGR, Rapid Sugar Film Coating System, is an aqueous, high-gloss sugar film coating system for pharmaceutical products. The coating system delivers a streamlined application process by reducing coating time from days to hours and improving manufacturing safety through the elimination of organic solvents, according to the company. The system is color matched to meet marketing and brand needs and is suited for environments where less automated equipment is prevalent.

Colorcon

Download Issue PDF
Articles in this issue
Designing a Single-Use Biopharmaceutical Process
Designing a Single-Use Biopharmaceutical Process
Material Traceability in Continuous Pharmaceutical Tablet Manufacturing
Material Traceability in Continuous Pharmaceutical Tablet Manufacturing
Establishing Correlation Between Aerosol and Surface Microbial Populations
Establishing Correlation Between Aerosol and Surface Microbial Populations
Analyzing Content Uniformity
Analyzing Content Uniformity
Figure 1.jpg
The Power of Synchrotron X-Ray Powder Diffraction for the Characterization of Pharmaceuticals
Impurity Testing
Impurity Testing
PF701807_small-225-1.jpg
Tabletop Peristaltic Liquid-Filling Machine
Ross-Tumble-Blenders-(1,-5-and-7.5-cu.ft.)_225.jpg
Safety Light Curtain Feature on Tumble Blenders
10346-Colorcon-SGR-logo-and-Render-225.jpg
Aqueous Sugar Film Coating System
LogTag-Serie_USB_klein_225.jpg
USB Data Logger for Temperature-Sensitive Products
Navigating Data Integrity in the Modern Lab
Maintaining Lab Data Integrity
Maintaining Lab Data Integrity
Barriers to ATMP Drug Development
A New Business Model for Pharma?
Managing Risk in a Complex Excipient Supply Chain
Managing Risk in a Complex Excipient Supply Chain
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Newly Opened Innovation Center in New Jersey Gives Avantor Advantage in Solving Life Sciences Challenges

Feliza Mirasol
November 15th 2024
Article

Avantor's newly launched expanded Innovation Center in Bridgewater, NJ, is designed for integrated workflows and features purpose-built collaboration spaces.

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

Jill Murphy
November 14th 2023
Podcast

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Merck and Ginkgo Bioworks’ Collaboration to Improve Biologics Manufacturing Has Reached Its First Milestone

Feliza Mirasol
November 13th 2024
Article

Under an ongoing partnership with Merck, known as MSD outside of the United States and Canada, Ginkgo Bioworks has achieved the first milestone in a project aimed at improving biologics production.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

TrakCel’s OCELLOS Platform Selected to Support Treatment Management of Five Upcoming Cell Therapy Products

Feliza Mirasol
November 13th 2024
Article

Manufacturers of five autologous or matched allogenic cell therapy products have selected TrakCel's IT platform, OCELLOS, to orchestrate the administration of these therapies, which are approved or expected to be approved in 2024.